Goldman Sachs’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-630,735
| Closed | -$14.9M | – | 4988 |
|
|
2023
Q4 | $14.9M | Buy |
630,735
+69,974
| +12% | +$1.65M | ﹤0.01% | 1789 |
|
|
2023
Q3 | $8.36M | Sell |
560,761
-12,384
| -2% | -$185K | ﹤0.01% | 2111 |
|
|
2023
Q2 | $6.28M | Sell |
573,145
-200,201
| -26% | -$2.19M | ﹤0.01% | 2397 |
|
|
2023
Q1 | $6.74M | Buy |
773,346
+688,132
| +808% | +$6M | ﹤0.01% | 2298 |
|
|
2022
Q4 | $534K | Sell |
85,214
-149,508
| -64% | -$937K | ﹤0.01% | 4061 |
|
|
2022
Q3 | $822K | Sell |
234,722
-20,321
| -8% | -$71.2K | ﹤0.01% | 3946 |
|
|
2022
Q2 | $753K | Sell |
255,043
-309,073
| -55% | -$913K | ﹤0.01% | 4131 |
|
|
2022
Q1 | $1.75M | Buy |
564,116
+136,996
| +32% | +$426K | ﹤0.01% | 3678 |
|
|
2021
Q4 | $1.44M | Buy |
427,120
+284,156
| +199% | +$961K | ﹤0.01% | 3742 |
|
|
2021
Q3 | $522K | Buy |
142,964
+601
| +0.4% | +$2.19K | ﹤0.01% | 4358 |
|
|
2021
Q2 | $621K | Buy |
142,363
+49,595
| +53% | +$216K | ﹤0.01% | 4319 |
|
|
2021
Q1 | $421K | Sell |
92,768
-848,214
| -90% | -$3.85M | ﹤0.01% | 4467 |
|
|
2020
Q4 | $5.4M | Buy |
940,982
+850,404
| +939% | +$4.88M | ﹤0.01% | 2432 |
|
|
2020
Q3 | $655K | Sell |
90,578
-624,397
| -87% | -$4.52M | ﹤0.01% | 3533 |
|
|
2020
Q2 | $2.5M | Sell |
714,975
-7,526
| -1% | -$26.3K | ﹤0.01% | 2716 |
|
|
2020
Q1 | $1.07M | Buy |
722,501
+342,100
| +90% | +$507K | ﹤0.01% | 3077 |
|
|
2019
Q4 | $746K | Buy |
380,401
+121,371
| +47% | +$238K | ﹤0.01% | 3471 |
|
|
2019
Q3 | $1.33M | Buy |
259,030
+118,278
| +84% | +$605K | ﹤0.01% | 3085 |
|
|
2019
Q2 | $1.01M | Sell |
140,752
-68,743
| -33% | -$492K | ﹤0.01% | 3189 |
|
|
2019
Q1 | $2.78M | Buy |
209,495
+114,946
| +122% | +$1.53M | ﹤0.01% | 2749 |
|
|
2018
Q4 | $744K | Buy |
94,549
+29,041
| +44% | +$229K | ﹤0.01% | 3264 |
|
|
2018
Q3 | $726K | Buy |
65,508
+5,211
| +9% | +$57.8K | ﹤0.01% | 3312 |
|
|
2018
Q2 | $809K | Sell |
60,297
-382,046
| -86% | -$5.13M | ﹤0.01% | 3306 |
|
|
2018
Q1 | $5.75M | Buy |
442,343
+420,936
| +1,966% | +$5.47M | ﹤0.01% | 2258 |
|
|
2017
Q4 | $197K | Buy |
+21,407
| New | +$197K | ﹤0.01% | 3829 |
|
|
2016
Q4 | – | Sell |
-16,554
| Closed | -$32K | – | 4591 |
|
|
2016
Q3 | $32K | Buy |
+16,554
| New | +$32K | ﹤0.01% | 4382 |
|
|
2015
Q1 | – | Sell |
-42,563
| Closed | -$418K | – | 4658 |
|
|
2014
Q4 | $418K | Buy |
+42,563
| New | +$418K | ﹤0.01% | 3480 |
|